Literature DB >> 19615628

Capturing the costs of end-of-life care: comparisons of multiple sclerosis, Parkinson's disease, and dementia.

Paul McCrone1.   

Abstract

The need for end-of-life care is going to increase substantially in many countries in the coming decades. In addition to considering the effectiveness of such care, it is also vital, given resource scarcity, to assess its costs and cost-effectiveness. Costs include the direct care inputs, other related services, and indirect costs, such as lost employment. These need to be measured in an appropriate way, and one relevant questionnaire is the Client Service Receipt Inventory. Studies of multiple sclerosis, Parkinson's disease, and dementia that have used this questionnaire are described in this article. What is clear is that the costs of providing end-of-life care can be high and that informal care from family members and friends accounts for a substantial amount of the overall costs.

Entities:  

Mesh:

Year:  2009        PMID: 19615628     DOI: 10.1016/j.jpainsymman.2009.04.006

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  13 in total

1.  Palliative care for the terminally ill in America: the consideration of QALYs, costs, and ethical issues.

Authors:  Y Tony Yang; Margaret M Mahon
Journal:  Med Health Care Philos       Date:  2012-11

Review 2.  Mental health and Parkinson's disease: from the cradle to the grave.

Authors:  Yassar A Alamri
Journal:  Br J Gen Pract       Date:  2015-05       Impact factor: 5.386

3.  Long-term care benefits may reduce end-of-life medical care costs.

Authors:  Stephen K Holland; Sharrilyn R Evered; Bruce A Center
Journal:  Popul Health Manag       Date:  2014-12       Impact factor: 2.459

4.  Cognitive interviewing of bereaved relatives to improve the measurement of health outcomes and care utilisation at the end of life in a mortality followback survey.

Authors:  Barbara Gomes; Paul McCrone; Sue Hall; Julia Riley; Jonathan Koffman; Irene J Higginson
Journal:  Support Care Cancer       Date:  2013-06-08       Impact factor: 3.603

5.  Financial hardship and the intensity of medical care received near death.

Authors:  Reginald D Tucker-Seeley; Gregory A Abel; Hajime Uno; Holly Prigerson
Journal:  Psychooncology       Date:  2014-07-23       Impact factor: 3.894

6.  Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study.

Authors:  Barbara Gomes; Paul McCrone; Sue Hall; Jonathan Koffman; Irene J Higginson
Journal:  BMC Cancer       Date:  2010-08-02       Impact factor: 4.430

7.  The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.

Authors:  Paul McCrone; Christine Anne Mary Payan; Martin Knapp; Albert Ludolph; Yves Agid; P Nigel Leigh; Gilbert Bensimon
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

8.  Informal Caregivers' Experiences of Caring of Multiple Sclerosis Patients: A Qualitative Study.

Authors:  Somayeh Gafari; Masoud F Khoshknab; Kian Nourozi; Eesa Mohamadi
Journal:  Iran J Nurs Midwifery Res       Date:  2017 May-Jun

9.  Treatment outcomes in palliative care: the TOPCare study. A mixed methods phase III randomised controlled trial to assess the effectiveness of a nurse-led palliative care intervention for HIV positive patients on antiretroviral therapy.

Authors:  Keira Lowther; Victoria Simms; Lucy Selman; Lorraine Sherr; Liz Gwyther; Hellen Kariuki; Aabid Ahmed; Zipporah Ali; Rachel Jenkins; Irene J Higginson; Richard Harding
Journal:  BMC Infect Dis       Date:  2012-11-06       Impact factor: 3.090

10.  Factors Associated with Transition from Community Settings to Hospital as Place of Death for Adults Aged 75 and Older: A Population-Based Mortality Follow-Back Survey.

Authors:  Anna E Bone; Wei Gao; Barbara Gomes; Katherine E Sleeman; Matthew Maddocks; Juliet Wright; Deokhee Yi; Irene J Higginson; Catherine J Evans
Journal:  J Am Geriatr Soc       Date:  2016-09-09       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.